1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South America Travel Vaccines Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South America Travel Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South America Travel Vaccines Market Regional Analysis
6.2 South America Travel Vaccines Market Revenue 2019-2028 (US$ Million)
6.3 South America Travel Vaccines Market Forecast Analysis
7. South America Travel Vaccines Market Analysis – by Product
7.1 Hepatitis A
- 7.1.1 Overview
- 7.1.2 Hepatitis A: South America Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Hepatitis B
- 7.2.1 Overview
- 7.2.2 Hepatitis B: South America Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Meningococcal Vaccines
- 7.3.1 Overview
- 7.3.2 Meningococcal Vaccines: South America Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. South America Travel Vaccines Market Analysis – by Application
8.1 Domestic Travel and Outbound Travel
- 8.1.1 Overview
- 8.1.2 Domestic Travel and Outbound Travel : South America Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. South America Travel Vaccines Market – South and Central America Analysis
9.1 Overview
9.2 South and Central America
- 9.2.1 South America Travel Vaccines Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 9.2.1.1 South America Travel Vaccines Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 Brazil:
South America Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 Brazil: South America Travel Vaccines Market Breakdown, by Product
- 9.2.1.1.2 Brazil: South America Travel Vaccines Market Breakdown, by Application
- 9.2.1.2 Argentina:
South America Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Argentina: South America Travel Vaccines Market Breakdown, by Product
- 9.2.1.2.2 Argentina: South America Travel Vaccines Market Breakdown, by Application
- 9.2.1.3 Rest of South and Central America :
South America Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 Rest of South and Central America : South America Travel Vaccines Market Breakdown, by Product
- 9.2.1.3.2 Rest of South and Central America : South America Travel Vaccines Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Abbott
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 GlaxoSmithKline plc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Merck & Co., Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Novartis AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Pfizer Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Sanofi
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations